CECIL LITIEMA: Open Payments
NPI 1609908243 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 19 payments from 6 companies in 2025. Trend: 2023 $359 · 2024 $624 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $169 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| PFIZER INC. | 2 | $32 |
| Abbott Laboratories | 2 | $30 |
| Novo Nordisk Inc | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: REPATHA, CAMZYOS, ELIQUIS, MERLIN@HOME, NEXLETOL.
Industry payments across CA — which companies pay providers there.
